<?xml version="1.0" encoding="UTF-8"?>
<ref id="B57-marinedrugs-16-00504" class="ref">
 <label class="label">57.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Roepke</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Diestel</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Bajbouj</surname>
    <given-names class="given-names">K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Walluscheck</surname>
    <given-names class="given-names">D.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Schonfeld</surname>
    <given-names class="given-names">P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Roessner</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Schneider-Stock</surname>
    <given-names class="given-names">R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Gali-Muhtasib</surname>
    <given-names class="given-names">H.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells</article-title>
  <source class="source">Cancer Biol. Ther.</source>
  <year class="year">2007</year>
  <volume class="volume">6</volume>
  <fpage class="fpage">160</fpage>
  <lpage class="lpage">169</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.4161/cbt.6.2.3575</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">17218778</pub-id>
 </element-citation>
</ref>
